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S U M M A R Y
Objectives: To evaluate the association between the income status of a country and the prevalence of
antimicrobial resistance (AMR) in the three most common bacteria causing infections in hospitals and in
the community: third-generation cephalosporin (3GC)-resistant Escherichia coli, methicillin-resistant
Staphylococcus aureus (MRSA), and 3GC-resistant Klebsiella species.
Methods: Using 2013–2014 country-speciﬁc data from the ResistanceMap repository and the World
Bank, the association between the prevalence of AMR in invasive samples and the gross national income
(GNI) per capita was investigated through linear regression with robust standard errors. To account for
non-linear association with the dependent variable, GNI per capita was log-transformed.
Results: The models predicted an 11.3% (95% conﬁdence interval (CI) 6.5–16.2%), 18.2% (95% CI 11–
25.5%), and 12.3% (95% CI 5.5–19.1%) decrease in the prevalence of 3GC-resistant E. coli, 3GC-resistant
Klebsiella species, and MRSA, respectively, for each log GNI per capita. The association was stronger for
3GC-resistant E. coli and Klebsiella species than for MRSA.
Conclusions: A signiﬁcant negative association between GNI per capita and the prevalence of MRSA and
3GC-resistant E. coli and Klebsiella species was found. These results underscore the urgent need for new
policies aimed at reducing AMR in resource-poor settings.
 2016 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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jou r nal h o mep ag e: w ww .e lsev ier . co m / loc ate / i j id1. Introduction
The emergence of antimicrobial resistance (AMR) is a complex
phenomenon and is intensiﬁed by selective pressure through
antibiotic use in humans, animals, and agriculture.1 The transmis-
sion of AMR to humans occurs from contact with animals
(including food), other humans, and the environment.1 Transmis-
sion is facilitated by several factors, including high population
density, lack of access to clean water, suboptimal sewage systems,
poor sanitation, and poor healthcare infection control practices, all
of which are more common in low- and middle-income countries
(LMIC).1 In addition, with the increasing consumption of anti-
microbials in humans, lack of regulation on antimicrobial use in
farming, and pharmaceutical industry pollution, it may not be
surprising that relatively higher levels of AMR among human
pathogens are being reported from LMIC.2,3 However, the* Corresponding author. Tel.: +1 202 939 3300; fax: +1 202 328 5170.
E-mail address: ramanan@cddep.org (R. Laxminarayan).
http://dx.doi.org/10.1016/j.ijid.2016.09.026
1201-9712/ 2016 The Authors. Published by Elsevier Ltd on behalf of International So
(http://creativecommons.org/licenses/by/4.0/).association between the income status of a country and prevalence
of AMR has not yet been published.
Escherichia coli, Klebsiella species, and Staphylococcus aureus are
the most common bacteria causing infections in hospitals and in
the community.2 The aims of this study were (1) to evaluate the
association between the income status of a country and the
prevalence of AMR in the three most common bacteria isolated
from invasive samples (third-generation cephalosporin (3GC)-
resistant E. coli, methicillin-resistant S. aureus (MRSA), and 3GC-
resistant Klebsiella species),2 and (2) to estimate the overall
prevalence of AMR among lower-middle-, upper-middle-, and
high-income economies.
2. Methods
Data from the World Bank (gross national income (GNI) per
capita) and from the ResistanceMap repository were used.
ResistanceMap is a repository of reliable antimicrobial resistance
data from hospitals and laboratory networks from around the
world.4ciety for Infectious Diseases. This is an open access article under the CC BY license
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Figure 1. Prevalence of third-generation cephalosporin-resistant (3GCR) Escherichia coli (A), 3GCR Klebsiella sp (B), and methicillin-resistant Staphylococcus aureus (C) by gross
national income per capita and predicted values with 95% conﬁdence intervals according to a linear regression model.
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ResistanceMap database for 2013 and 2014 were selected.
Countries with fewer than 30 samples and those for which
samples came from a single hospital were excluded. Conﬁdence
intervals (CI) for proportions were estimated using the Wilson
method. To facilitate the interpretation of the results, the
proportion of isolates tested that were resistant was modeled as
a continuous variable using linear regression with robust standard
errors. GNI per capita was measured in US dollars according to
2014 World Bank data. To account for non-linear association with
the dependent variable, GNI per capita was natural log-trans-
formed. GNI per capita is presented on a log scale in the ﬁgures.
3. Results
The association between the percentage of 3GC-resistant E. coli
and GNI per capita for the 45 countries that met the study criteria is
presented in Figure 1A. The model predicted an 11.3% (95% CI 6.5–
16.2%) decrease in the prevalence of 3GC-resistant E. coli for each
log GNI per capita and was able to explain 65% of the variance
(R2 = 0.6486). When countries were grouped by their GNI per
capita into high-, upper-middle-, and lower-middle-income
economies, the predicted prevalence of 3GC-resistant E. coli was
11.5% (95% CI 9.2–13.8%), 30.7% (95% CI 19–42.4%), and 77.6% (95%
CI 71.2–84.1%), respectively.
The association between the percentage of 3GC-resistant
Klebsiella sp and GNI per capita for the 43 countries that met
the study criteria is presented in Figure 1B. The model predicted an
18.2% (95% CI 11–25.5%) decrease in the prevalence of 3GC-
resistant Klebsiella sp for each log GNI per capita and was able to
explain 58% of the variance (R2 = 0.5745). When countries were
grouped by their GNI per capita into high-, upper-middle-, and
lower-middle-income economies, the predicted prevalence of
3GC-resistant Klebsiella sp was 30.6% (95% CI 20.9–40.2%), 56.7%
(95% CI 40.6–72.8%), and 78.9% (95% CI 69–88.7%), respectively.
The association between the percentage of MRSA and GNI per
capita for the 43 countries that met the study criteria is presented
in Figure 1C. The model predicted a 12.3% (95% CI 5.5–19.1%)
decrease in the prevalence of MRSA for each log GNI per capita and
was able to explain 41% of the variance (R2 = 0.4079). When
countries were grouped by their GNI per capita into high-, upper-
middle-, and lower-middle-income economies, the predicted
prevalence of MRSA was 19.2% (95% CI 10.2–28.3%), 29% (95% CI
22–36.1%), and 36.4% (95% CI 23.7–49%), respectively.
4. Discussion
The burden of bacterial infections is higher in LMIC,5 and the
present study results demonstrate that they have a higher
prevalence of AMR too. This combination is likely to have
devastating consequences for LMIC economies. First, infections
caused by resistant organisms are associated with increased
mortality and health costs.2,6,7 Second, antibiotics that are effective
against bacteria with AMR are more expensive and are not
affordable for a substantial number of people living in resource-
limited settings.8 Third, increasing the use of effective antibioticsagainst bacteria with AMR will lead to higher resistance to last-
resort antibiotics. In fact, carbapenem consumption is increasing at
a rapid pace in poor economies,9 leading to an increasing
prevalence of carbapenem-resistant E. coli and Klebsiella sp.3
The association was stronger for 3GC-resistant E. coli and
Klebsiella sp than for MRSA. This ﬁnding is consistent with the
conditions that facilitate the transmission of AMR in developing
countries. E. coli and Klebsiella sp are part of the human gut
microbiota, and the spread of these organisms is facilitated by
suboptimal sewage systems, poor sanitation, and a lack of access to
clean water. Previous studies have demonstrated a high prevalence
of AMR in surface water and ground water in developing
countries.1 Improving sewage systems and access to clean water
is likely to have a greater impact on reducing the transmission of
AMR in E. coli and Klebsiella sp than in contact-transmitted bacteria
such as MRSA.
A strong negative association was found between the income
status of a country and the prevalence of AMR in invasive isolates.
The ﬁndings of this study underscore the urgent need for the
implementation of policies to improve environmental sanitation,
curb inappropriate antibiotic use, increase vaccination rates,
improve laboratory capacity, and establish infection control, and
antimicrobial stewardship programs in healthcare facilities in
developing countries.
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